Taken together, these findings suggest that GEN can enhance the radiosensitivity of NSCLC cells through reducing plasmic Bcl-xL levels and promoting IR-induced DNA damage and apoptosis. This evidence concerns the gene BCL2L1 and non-small cell lung carcinoma.